Rather, when she was still just a preteen herself, Lohan pulled off portraying both Hallie and Annie—complete with Annie's posh London accent—and was a key factor in making this movie the fan-favorite cult classic that it is today. Somehow, it's been nearly 30 years since that movie debuted, and Lohan recently sat down with Parade to share what it's like looking back on that legacy now.
About whether Lohan identified more with Hallie or Annie as a kid, Lohan shared, "I think always a bit of both, because I'm super feminine, but I'm also a little tomboy. So, I think I was both. Long hair, I like long hair better, but when I was young, I wanted the Jennifer Aniston haircut, so I was Hallie in that sense. But a little bit of both."
Lohan has just worked on a campaign featuring the Reese's Oreo cup, which Parent Trap fans will also connect with, as a major factor in Hallie and Annie's discovery that they were actually twins came about when they both revealed their love of Oreos with peanut butter.
The campaign saw Lohan partner with actress and comedian Amy Sedaris and actress and director Patricia Arquette on a new ad spot, directed by Arquette. A direct callback to The Parent Trap, the video sees Lohan helping twins—both played by Sedaris—come together.
Hence then, the article about lindsay lohan reflects on nearly 30 years of the parent trap and how it still resonates today exclusive was published today ( ) and is available on Parade ( Saudi Arabia ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Lindsay Lohan Reflects on Nearly 30 Years of 'The Parent Trap'—And How It Still Resonates Today (Exclusive) )
Also on site :
- Kevin Warsh’s first big press conference shines a spotlight on confusion over how the Fed actually measures inflation
- Ractigen Therapeutics Announces U.S. FDA IND Clearance for First-in-Class saRNA Candidate RAG-1C to Treat Proliferative Vitreoretinopathy
- EA expect their $55 billion sale to Saudi Arabia and private equity firms to close next week, with "all regulatory approvals required" in place